BioRestorative Therapies, Inc. (BRTX)
1.10
-0.05
(-4.35%)
USD |
NASDAQ |
Jan 20, 12:33
BioRestorative Therapies EPS Diluted (Quarterly): -0.3333 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| The Oncology Institute, Inc. | -0.1413 |
| CEL-SCI Corp. | -0.7611 |
| AIM ImmunoTech, Inc. | -1.567 |
| IGC Pharma, Inc. | -0.0201 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.038M |
| Revenue (Quarterly) | 0.0118M |
| Total Expenses (Quarterly) | 3.050M |
| Enterprise Value | 5.732M |
| Gross Profit Margin (Quarterly) | -435.6% |
| Profit Margin (Quarterly) | -25.75K% |
| Earnings Yield | -137.5% |
| Normalized Earnings Yield | -149.73 |